Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. MU
5. META
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Lantern Pharma (LTRN), Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
(NASDAQ: LTRN) Delayed: 3.85 -0.03 (0.77%)
Previous Close $3.88    52 Week High $ 
Open $3.76    52 Week Low $ 
Day High $3.88    P/E N/A 
Day Low $3.76    EPS $ 
Volume 51,602